Furosemida Aphar may be available in the countries listed below.
Ingredient matches for Furosemida Aphar
Furosemide is reported as an ingredient of Furosemida Aphar in the following countries:
- Spain
International Drug Name Search
Furosemida Aphar may be available in the countries listed below.
Furosemide is reported as an ingredient of Furosemida Aphar in the following countries:
International Drug Name Search
Enalapril Juventus may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril Juventus in the following countries:
International Drug Name Search
Ankisol may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Ankisol in the following countries:
International Drug Name Search
Epinephrine bitartrate (a derivative of Epinephrine) is reported as an ingredient of Bronitin Mist in the following countries:
International Drug Name Search
Xylasan may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Xylazine hydrochloride (a derivative of Xylazine) is reported as an ingredient of Xylasan in the following countries:
International Drug Name Search
Andractim may be available in the countries listed below.
Androstanolone is reported as an ingredient of Andractim in the following countries:
International Drug Name Search
Merdaten may be available in the countries listed below.
Mirtazapine is reported as an ingredient of Merdaten in the following countries:
International Drug Name Search
Lattulosio Angenerico may be available in the countries listed below.
Lactulose is reported as an ingredient of Lattulosio Angenerico in the following countries:
International Drug Name Search
Lipizem may be available in the countries listed below.
Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Lipizem in the following countries:
International Drug Name Search
Peptoci may be available in the countries listed below.
Famotidine is reported as an ingredient of Peptoci in the following countries:
International Drug Name Search
Femiderm TTS may be available in the countries listed below.
Estradiol is reported as an ingredient of Femiderm TTS in the following countries:
International Drug Name Search
Klimicin may be available in the countries listed below.
Clindamycin is reported as an ingredient of Klimicin in the following countries:
Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Klimicin in the following countries:
Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Klimicin in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Rec.INN
0035554-44-0
C14-H14-Cl2-N2-O
297
Antifungal agent for topical use
1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl]-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Gynefix may be available in the countries listed below.
Ascorbic Acid is reported as an ingredient of Gynefix in the following countries:
International Drug Name Search
Flumycozal may be available in the countries listed below.
Fluconazole is reported as an ingredient of Flumycozal in the following countries:
International Drug Name Search
MS Direct may be available in the countries listed below.
Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of MS Direct in the following countries:
International Drug Name Search
Rec.INN
J01CA08
0032886-97-8
C21-H33-N3-O5-S
439
Antibacterial: Penicillin, penicillinase-sensitive
(2S,5R,6R)-6-[(Azepan-1-ylmethylen)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carbonsäure-2,2-dimethylpropanoyloxymethyl (IUPAC)
Hydroxymethyl (2S,5R,6R)-6-[[(hexahydro-1H-azepin-1-yl)methylene]-amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate pivalate (ester) (WHO)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Furosemid EEL may be available in the countries listed below.
Furosemide is reported as an ingredient of Furosemid EEL in the following countries:
International Drug Name Search
Midazolam AccordHealthcare may be available in the countries listed below.
Midazolam hydrochloride (a derivative of Midazolam) is reported as an ingredient of Midazolam AccordHealthcare in the following countries:
International Drug Name Search
Lincmix may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Lincmix in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Buprenorphine (buprenorphine systemic) is a member of the drug class narcotic analgesics and is used to treat Opiate Dependence and Pain.
US matches:
Rec.INN
N02AE01,N07BC01,N07BC51
0052485-79-7
C29-H41-N-O4
467
Opioid analgesic
(5R,6R,6R,7R,9R,13S,14S)-17-Cyclopropylmethyl-7-[(S)-3,3-dimethyl-2-hydroxybutan-2-yl-]-6-methoxy-4,5-epoxy-6,14-ethanomorphinan-3-ol (IUPAC)
21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine (WHO)
6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-, [5α,7α(S)]-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Thiospen may be available in the countries listed below.
Methylmethionine Sulfonium Chloride is reported as an ingredient of Thiospen in the following countries:
International Drug Name Search
Rivodarone may be available in the countries listed below.
Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Rivodarone in the following countries:
International Drug Name Search
In the US, Corlopam (fenoldopam systemic) is a member of the drug class agents for hypertensive emergencies and is used to treat Hypertensive Emergency and Prevention of Radiographic Contrast Nephropathy.
US matches:
Fenoldopam is reported as an ingredient of Corlopam in the following countries:
Fenoldopam mesilate (a derivative of Fenoldopam) is reported as an ingredient of Corlopam in the following countries:
International Drug Name Search
In the US, Jumex is a member of the following drug classes: dopaminergic antiparkinsonism agents, monoamine oxidase inhibitors and is used to treat ADHD, Depression and Parkinson's Disease.
Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Jumex in the following countries:
International Drug Name Search
In the US, Innohep (tinzaparin systemic) is a member of the drug class heparins and is used to treat Deep Vein Thrombosis.
US matches:
UK matches:
Tinzaparin Sodium is reported as an ingredient of Innohep in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Titretta may be available in the countries listed below.
Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Titretta in the following countries:
Paracetamol is reported as an ingredient of Titretta in the following countries:
International Drug Name Search
Primovist may be available in the countries listed below.
UK matches:
Gadoxetic Acid disodium (a derivative of Gadoxetic Acid) is reported as an ingredient of Primovist in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Arheuma may be available in the countries listed below.
Leflunomide is reported as an ingredient of Arheuma in the following countries:
International Drug Name Search
Lupentil may be available in the countries listed below.
Flupentixol dihydrochloride (a derivative of Flupentixol) is reported as an ingredient of Lupentil in the following countries:
International Drug Name Search
Euclorina may be available in the countries listed below.
Tosylchloramide Sodium is reported as an ingredient of Euclorina in the following countries:
International Drug Name Search
Antilip may be available in the countries listed below.
Fenofibrate is reported as an ingredient of Antilip in the following countries:
International Drug Name Search
A-Nox may be available in the countries listed below.
Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of A-Nox in the following countries:
International Drug Name Search
Telavancin Hydrochloride may be available in the countries listed below.
Telavancin Hydrochloride (USAN) is known as Telavancin in the US.
International Drug Name Search
Glossary
| USAN | United States Adopted Name |
Perivasc may be available in the countries listed below.
Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Perivasc in the following countries:
International Drug Name Search
Phytoral may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Phytoral in the following countries:
International Drug Name Search
Killitch may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Benzyl Benzoate is reported as an ingredient of Killitch in the following countries:
International Drug Name Search
Fluoxetina Decrox may be available in the countries listed below.
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Decrox in the following countries:
International Drug Name Search
Molsidomin AL may be available in the countries listed below.
Molsidomine is reported as an ingredient of Molsidomin AL in the following countries:
International Drug Name Search
Pioglitazone Hydrochloride may be available in the countries listed below.
Pioglitazone Hydrochloride (USAN) is known as Pioglitazone in the US.
International Drug Name Search
Glossary
| USAN | United States Adopted Name |
Cloxacillin Benzathine may be available in the countries listed below.
Cloxacillin Benzathine (BANM) is known as Cloxacillin in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
Cefzon may be available in the countries listed below.
Cefdinir is reported as an ingredient of Cefzon in the following countries:
International Drug Name Search
MCP Sandoz may be available in the countries listed below.
Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of MCP Sandoz in the following countries:
International Drug Name Search
In the US, Phanasin is a member of the drug class expectorants and is used to treat Bronchitis, Cough and Fibromyalgia.
Guaifenesin is reported as an ingredient of Phanasin in the following countries:
International Drug Name Search
Lisinopril + HCT 1A Pharma may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Lisinopril + HCT 1A Pharma in the following countries:
Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril + HCT 1A Pharma in the following countries:
International Drug Name Search
Gemcitabin Xellex may be available in the countries listed below.
Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemcitabin Xellex in the following countries:
International Drug Name Search
Prelar Depot may be available in the countries listed below.
Leuprorelin acetate (a derivative of Leuprorelin) is reported as an ingredient of Prelar Depot in the following countries:
International Drug Name Search
Fenylbutazone may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Phenylbutazone is reported as an ingredient of Fenylbutazone in the following countries:
International Drug Name Search
Emlip-5 may be available in the countries listed below.
Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Emlip-5 in the following countries:
International Drug Name Search
Ferrum Hausmann Retard may be available in the countries listed below.
Ferrous Fumarate is reported as an ingredient of Ferrum Hausmann Retard in the following countries:
International Drug Name Search
In the US, Exjade (deferasirox systemic) is a member of the drug class chelating agents and is used to treat Hemosiderosis.
US matches:
UK matches:
Deferasirox is reported as an ingredient of Exjade in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Ciprofloxacin OGB Dexa may be available in the countries listed below.
Ciprofloxacin lactate (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprofloxacin OGB Dexa in the following countries:
International Drug Name Search
Cardiatone may be available in the countries listed below.
Spironolactone is reported as an ingredient of Cardiatone in the following countries:
International Drug Name Search
Eltrombopag Olamine may be available in the countries listed below.
Eltrombopag Olamine (USAN) is known as Eltrombopag in the US.
International Drug Name Search
Glossary
| USAN | United States Adopted Name |
Biprel may be available in the countries listed below.
Indapamide is reported as an ingredient of Biprel in the following countries:
Perindopril erbumine (a derivative of Perindopril) is reported as an ingredient of Biprel in the following countries:
International Drug Name Search
Alphazol may be available in the countries listed below.
Alfacalcidol is reported as an ingredient of Alphazol in the following countries:
International Drug Name Search
Hidantoina may be available in the countries listed below.
Phenytoin is reported as an ingredient of Hidantoina in the following countries:
Phenytoin sodium salt (a derivative of Phenytoin) is reported as an ingredient of Hidantoina in the following countries:
International Drug Name Search
Etoposide Phosphate may be available in the countries listed below.
Etoposide Phosphate (USAN) is known as Etoposide in the US.
International Drug Name Search
Glossary
| USAN | United States Adopted Name |
Amdinocillin Pivoxil may be available in the countries listed below.
Amdinocillin Pivoxil (USAN) is also known as Pivmecillinam (Rec.INN)
International Drug Name Search
Glossary
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Eroxim may be available in the countries listed below.
Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Eroxim in the following countries:
International Drug Name Search
Biocalyptol may be available in the countries listed below.
Pholcodine is reported as an ingredient of Biocalyptol in the following countries:
International Drug Name Search
Amikacina Biocrom may be available in the countries listed below.
Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amikacina Biocrom in the following countries:
International Drug Name Search
Restandol® TestocapsTM 40mg capsule, soft.
Each capsule contains Testosterone Undecanoate 40.0mg which is equivalent to 25.3mg testosterone.
For excipients, see 6.1.
Oval, glossy capsules, transparent, orange in colour, with a yellow oily fill.
Clinical Indications
Testosterone replacement therapy in male hypogonadal disorders, for example:
after castration;
eunuchoidism;
hypopituitarism;
endocrine impotence;
male climacteric symptoms like decreased libido and decreased mental and physical activity;
certain types of infertility due to disorders of spermatogenesis
Testosterone therapy may also be indicated in osteoporosis due to androgenic deficiency.
Dosage
Adults
The initial dosage required will usually be 120-160 mg daily for 2-3 weeks. Subsequent dosage (40-120 mg daily) should be based on the clinical effect obtained during the first weeks of therapy.
Elderly Patients
It should be noted that smaller and less frequent doses may achieve the same response.
Children
Safety and efficacy has not been determined in children.
Administration
Oral.
To ensure absorption, Restandol Testocaps must be taken with a normal meal, if necessary with a little fluid, and be swallowed whole without chewing. It is preferable that half of the daily dose be taken in the morning and the other half in the evening. If an uneven number of capsules is taken daily, the greater part should be taken in the morning.
Pregnancy
Breast feeding
Known or suspected prostatic or mammary carcinoma;
History of liver tumours
Hypersensitivity to the active substance or to any of the excipients.
Physicians should consider patients receiving Restandol Testocaps for monitoring before the start of treatment, at quarterly intervals for the first 12 months and yearly thereafter for the following parameters:
• digital rectal examination (DRE) of the prostate and PSA in men over the age of 45 years, to exclude prostate cancer (see section 4.3)
• hematocrit and hemoglobin to exclude polycythemia. In case of severe polycythemia, treatment with Restandol Testocaps should be stopped or the dosage should be lowered.
Patients, especially the elderly, with the following conditions should be monitored:
Pre-existing cardiac, renal or hepatic disease since oedema with or without congestive heart failure may result from androgen treatment. In addition to discontinuation of the drug, diuretic therapy may be required.
Mammary carcinoma, hypernephroma, bronchial carcinoma, and skeletal metastases, since these conditions may produce hypercalcaemia or hypercalciuria which may in turn be exacerbated by androgen therapy. If hypercalcaemia or hypercalciuria develops treatment should be discontinued.
Androgens should be used cautiously in prepubertal boys to avoid premature epiphyseal closure or precocious sexual development.
Caution is required when administering with anticoagulants and anti-diabetic agents, since androgens in general can affect glucose tolerance and the action of anticoagulants (see also section 4.5)
There is insufficient evidence for a recommendation regarding the safety of treatment with testosterone esters in men with sleep apnea. Good clinical judgment and caution should be employed in subjects with risk factors such as adiposity or chronic lung diseases.
Androgen therapy should only be used in male hypogonadism in which testosterone levels have been demonstrated to be low.
In treating males, stimulation to the point of increasing nervous, mental and physical activities beyond the patient's cardiovascular capacity should be avoided.
Tumours and other histological abnormalities and disturbances of liver function have been reported in patients subjected to prolonged treatment with some testosterone derivatives. Most of these compounds were 17-alpha alkyl derivatives but a smaller number of cases have occurred with certain 17-beta esters of testosterone. The possibility that such changes result from the use of Restandol Testocaps has not been excluded.
If undesirable effects occur, administration of Restandol Testocaps should be discontinued and/or resumed at a lower dose.
Restandol Testocaps contains Sunset Yellow (E110, FD&C Yellow no. 6) which may cause allergic reactions.
Concurrent administration of liver enzyme inducing drugs such as rifampicin, barbiturates, carbamazepine, dichloralphenazone, phenylbutazone, phenytoin or primidone may decrease the effect of Restandol Testocaps.
Androgens may improve glucose tolerance and decrease the need for insulin or other anti-diabetic medicines in diabetic subjects. Patients on insulin or other anti-diabetic medication should be closely monitored, with therapy adjusted as appropriate (See also section 4.4).
High doses of androgens may enhance the anticoagulant action of coumarine type agents and additional monitoring of INR and adjustment of anticoagulant dose may need to be considered
Restandol Testocaps must be taken with a normal meal to ensure absorption.
There are no adequate data for the use of Restandol Testocaps in pregnant women. In view of the risk of virilisation of the foetus, Restandol Testocaps should not be used during pregnancy. Treatment with Restandol Testocaps should be discontinued when pregnancy occurs.
There are no adequate data for the use of Restandol Testocaps during lactation. Therefore, Restandol Testocaps should not be used during lactation.
Restandol Testocaps has no influence on the ability to drive or use machines.
If Restandol Testocaps are used in children precocious sexual development and cessation of the bone growth may occur by premature and irreversible epiphyseal closure.
In women, androgens have been described to cause symptoms of virilisation such as hirsutism, acne and voice changes (deepening, hoarsening). The voice changes may be irreversible.
Other adverse drug reactions of testosterone treatments that have been reported are (see also Section 4.4):
Prostatic growth, progression of a sub-clinical prostatic cancer, PSA increased, urinary obstruction, gynaecomastia, pruritis, nausea, cholestatic jaundice, changes in liver function tests, increased or decreased libido, depression, nervousness, mood disturbances, myalgia.
With high doses and prolonged treatment electrolyte changes (sodium, potassium, calcium, inorganic phosphate and water retention), hypertension, oligozospermia, or azospermia, priaprism, changes in lipid metabolism, polycythaemia, oligo- or amenorrhoea.
In a few patients diarrhoea and abdominal pain or discomfort have been reported during use of Restandol Testocaps.
High doses of Restandol Testocaps may cause gastrointestinal complaints due to the castor oil present in the capsule. Treatment consists of supportive measures.
Pharmacotherapeutic group: Androgens. ATC code G03B A03
Restandol Testocaps, after oral administration, delivers physiological amount of testosterone in the circulation. Treatment of hypogonadal men also results in a clinically significant rise of plasma concentrations of dihydrotestosterone and oestradiol, as well as a decrease of SHBG (sex hormone binding globulin). Treatment of males with primary (hypergonadotropic) hypogonadism results in a normalization of gonadotropin levels.
Endogenous androgens, principally testosterone, secreted by the testes and its major metabolite DHT, are responsible for the development of the external and internal genital organs and for maintaining the secondary sexual characteristics (stimulating hair growth, deepening of the voice, development of the libido); for a general effect on protein anabolism; for development of skeletal muscle and body fat distribution; for a reduction in urinary nitrogen, sodium, potassium, chloride, phosphate and water excretion.
Androgens are also responsible for the growth spurt of adolescence and for the eventual termination of linear growth and stimulate the production of red blood cells by enhancing erythropoietin production.
The effects of testosterone in some target organs arise after peripheral conversion of testosterone to oestradiol, which then binds to oestrogen receptors in the target cell nucleus e.g. the pituitary, fat, brain, bone and testicular Leydig cells.
Exogenous administration of androgens inhibits endogenous testosterone release. With large doses of exogenous androgens, spermatogenesis may be suppressed.
Absorption
Restandol Testocaps must be taken with a normal meal or breakfast to ensure absorption. Food enhances the absorption of Restandol Testocaps: In healthy volunteers the AUC of testosterone was increased more than 12 –fold compared with fasted conditions when Restandol Testocaps was taken with a normal meal. No differences were found in the AUC of testosterone when Restandol Testocaps was taken with a normal meal (containing 18.8 grams of fat) as compared to a high fat meal (containing 44.1 grams of fat). The absorption is about 7%. Following oral administration of Restandol Testocaps, an important part of the active substance testosterone undecanoate is co-absorbed with the lipophilic solvent from the intestine into the lymphatic system, thus circumventing the first pass inactivation by the liver.
Distribution
From the lymphatic system testosterone undecanoate is released into the plasma. Single administration of 20-80 mg Restandol Testocaps to postmenopausal women leads to peak-levels of total plasma testosterone of approximately 1.5-2.0, 2.5-5.5 and 5.2-10.3ng/ml after a dose of 20, 40 and 80 mg Restandol Testocaps, respectively. These levels are reached approximately 5-6 h (tmax) after administration. Plasma testosterone levels remain elevated for at least 8 hours. In Japanese women the testosterone levels are about two fold higher.
During steady state after 28 days of administration plasma levels of total testosterone in hypogonadal men were increased after administration of 40 mg t.i.d, 40 b.i.d+80 mg, 80 mg b.i.d and 80 mg t.i.d. The dose of 80 mg b.i.d or 80 mg t.i.d. resulted in levels in the male physiological range for a considerable proportion of the time during the day. Testosterone and testosterone undecanoate display a high (over 97%) non-specific binding to plasma proteins and sex hormone binding globulin in in vitro tests.
Biotransformation
In plasma and tissues testosterone undecanoate is hydrolyzed to yield the natural male androgen testosterone. Testosterone is further metabolized to dihydrotestosterone and oestradiol.
Elimination
Testosterone, oestradiol and dihydrotestosterone are metabolized via the normal pathways. Excretion mainly takes place via the urine as conjugates of etiocholanolone and androsterone.
Linearity
Dose-linearity has been demonstrated for 20-240 mg/day.
Preclinical data reveal no hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential and toxicity to reproduction.
Each capsule contains
Castor oil
Propylene glycol laurate (E477)
Capsule shell
Glycerin
Sunset Yellow (E110)
Gelatin
Printing ink
Opacode WB® white
Auxiliary substances
Medium-chain triglycerides
Lecithin
None
3 years
Do not store above 30 °C.
Do not refrigerate or freeze.
Keep the blister in the outer carton.
A box of Restandol Testocaps contains either 3 or 6 sachets, each containing a blister with 10 capsules
Any unused product or waste material should be disposed of in accordance with local requirements
See also “Special precautions for storage” (section 6.4) and “Posology and method of administration” (section 4.2)
Organon Laboratories Limited
Cambridge Science Park
Milton Road
Cambridge
CB4 0FL
0065/0059
14/1/81 / 8/11/2004
04 October 2011
Prescription Only Medicine
|
Polyspor may be available in the countries listed below.
Gramicidin is reported as an ingredient of Polyspor in the following countries:
Polymyxin B sulfate (a derivative of Polymyxin B) is reported as an ingredient of Polyspor in the following countries:
International Drug Name Search
Penicillin V AbZ may be available in the countries listed below.
Phenoxymethylpenicillin potassium (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Penicillin V AbZ in the following countries:
International Drug Name Search
Gentazol may be available in the countries listed below.
Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentazol in the following countries:
International Drug Name Search
Augbactam may be available in the countries listed below.
Amoxicillin is reported as an ingredient of Augbactam in the following countries:
Clavulanic Acid is reported as an ingredient of Augbactam in the following countries:
International Drug Name Search
Carbazochrome Sodium Sulfonate may be available in the countries listed below.
Carbazochrome Sodium Sulfonate (JAN) is also known as Carbazochrome (Rec.INN)
International Drug Name Search
Glossary
| JAN | Japanese Accepted Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Adenosin Ebewe may be available in the countries listed below.
Adenosine is reported as an ingredient of Adenosin Ebewe in the following countries:
International Drug Name Search
Triniton may be available in the countries listed below.
Dihydralazine hydrogen sulfate (a derivative of Dihydralazine) is reported as an ingredient of Triniton in the following countries:
Hydrochlorothiazide is reported as an ingredient of Triniton in the following countries:
Reserpine is reported as an ingredient of Triniton in the following countries:
International Drug Name Search
In the US, Peridex (chlorhexidine topical) is a member of the following drug classes: antiseptic and germicides, mouth and throat products and is used to treat Gingivitis, Mucositis and Periodontitis.
US matches:
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Peridex in the following countries:
International Drug Name Search
Bifolvelin may be available in the countries listed below.
Propiverine hydrochloride (a derivative of Propiverine) is reported as an ingredient of Bifolvelin in the following countries:
International Drug Name Search
Tricloryl may be available in the countries listed below.
Triclofos sodium salt (a derivative of Triclofos) is reported as an ingredient of Tricloryl in the following countries:
International Drug Name Search
Penject may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Penject in the following countries:
International Drug Name Search
Chlohexscrub Solution 4% may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Chlohexscrub Solution 4% in the following countries:
International Drug Name Search
Izometazone may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Izometazone in the following countries:
International Drug Name Search
Trandolapril-DP may be available in the countries listed below.
Trandolapril is reported as an ingredient of Trandolapril-DP in the following countries:
International Drug Name Search
Clobetamil may be available in the countries listed below.
Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Clobetamil in the following countries:
International Drug Name Search
Liaderyl may be available in the countries listed below.
Tenoxicam is reported as an ingredient of Liaderyl in the following countries:
International Drug Name Search
Tiadénol may be available in the countries listed below.
Tiadénol (DCF) is also known as Tiadenol (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Pure may be available in the countries listed below.
Halazone is reported as an ingredient of Pure in the following countries:
International Drug Name Search
Feloday may be available in the countries listed below.
Felodipine is reported as an ingredient of Feloday in the following countries:
International Drug Name Search
Albipenal may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ampicillin is reported as an ingredient of Albipenal in the following countries:
International Drug Name Search
Rec.INN
C03BA09
0001084-65-7
C10-H13-N-O4-S2
275
Diuretic agent
2H-1-Benzothiopyran-7-sulfonamide, 3,4-dihydro-6-methyl-, 1,1-dioxide
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Exterol may be available in the countries listed below.
UK matches:
Urea peroxyde (a derivative of Urea) is reported as an ingredient of Exterol in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
RAN-Carvedilol may be available in the countries listed below.
Carvedilol is reported as an ingredient of RAN-Carvedilol in the following countries:
International Drug Name Search
Pyrazinamid may be available in the countries listed below.
Pyrazinamide is reported as an ingredient of Pyrazinamid in the following countries:
International Drug Name Search
PZC may be available in the countries listed below.
Perphenazine is reported as an ingredient of PZC in the following countries:
International Drug Name Search
Calcium D3 axcount may be available in the countries listed below.
Calcium Carbonate is reported as an ingredient of Calcium D3 axcount in the following countries:
Colecalciferol is reported as an ingredient of Calcium D3 axcount in the following countries:
International Drug Name Search
Rec.INN
B01AA02
0000083-12-5
C15-H10-O2
222
Anticoagulant agent: Vitamin K antagonist
1H-Indene-1,3(2H)-dione, 2-phenyl-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |